Home/Topics/Companies & Institutions/Sun Pharmaceutical Industries Ltd.

🏢Organization Dossier

Sun Pharmaceutical Industries Ltd.

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

12 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

Markets, IPOs & Wealth 05 Nov 2026, 02:00 PM IST

Sun Pharma Shares in Focus as Traders Track Current Price Action Amid Broader Market Caution

Sun Pharmaceutical Industries Ltd. is drawing close market attention as investors monitor its live share price against a backdrop of cautious trading across Indian equities. The stock’s movement is being read not just as a company-specific signal, but also as a gauge of sentiment toward large-cap healthcare names in a volatile macro environment. With fiscal and macroeconomic cues still shaping risk appetite, Sun Pharma’s current trading pattern is likely to remain under scrutiny from institutional and retail investors alike. Market participants are watching for whether the counter can sustain momentum, consolidate, or face pressure from broader sector rotation.

By RDU Global Wire5 min read

Healthcare, Pharma & Life Sciences01 Nov 2026, 02:00 PM IST

Sun Pharma Q2 Profit Falls 36% as Litigation and Deal Costs Weigh on Earnings

Sun Pharmaceutical Industries reported a 36% drop in second-quarter net profit to Rs 1,989 crore, as exceptional litigation and acquisition-related expenses sharply reduced earnings. Revenue rose 11.8% on the back of strong domestic and emerging-market demand, but weakness in the US formulations business tempered the overall performance.

4 min readRead →

Clean Energy & Climate Transition22 Oct 2026, 08:00 AM IST

Nature Study Shows De Novo Artificial Metalloenzymes Can Be Tailored for Enantioselective Photocatalysis

A new Nature study reports a de novo design strategy for artificial metalloenzyme photocatalysts capable of steering reactions toward a preferred enantiomer, a long-sought goal in selective chemistry. The work strengthens the case for protein-engineered catalysts as a platform for cleaner, more precise chemical manufacturing with potential relevance to pharmaceuticals and low-waste industrial synthesis.

5 min readRead →

Clean Energy & Climate Transition16 Oct 2026, 11:32 AM IST

Single-Atom Carbon Transfer Opens New Route to 3D Molecular Architectures

Scientists have reported a catalytic method that transfers a single carbon atom to fuse flat molecules into rigid three-dimensional spirocyclic structures, a development that could reshape how complex organic compounds are built. The advance, published in Nature, points to a more direct way to construct high-value molecular frameworks relevant to pharmaceuticals, materials science, and potentially cleaner chemical manufacturing.

5 min readRead →

Clean Energy & Climate Transition16 Oct 2026, 12:15 AM IST

Single-Carbon Catalysis Opens a New Route to 3D Molecular Architectures

Scientists have reported a catalytic method that transfers a single carbon atom to fuse flat molecules into rigid three-dimensional spirocycles, a structural advance that could reshape how complex chemicals are built. The work, published in Nature, points to a more direct way to assemble high-value molecular frameworks relevant to pharmaceuticals, materials science, and potentially cleaner chemical manufacturing.

5 min readRead →

Markets, IPOs & Wealth13 Oct 2026, 03:23 AM IST

Quant Mutual Fund Sells Rs 190 Crore Jubilant Pharmova Stake as Abakkus Steps In; Company Clears Rs 800 Crore Debt-Raising Plan

Quant Mutual Fund has pared a significant holding in Jubilant Pharmova through bulk deals, selling 20.81 lakh shares worth Rs 190.47 crore, while Abakkus Four2Eight Opportunities Fund acquired 11 lakh shares in the same trading window. The transactions came as the pharmaceutical company approved plans to raise up to Rs 800 crore through non-convertible debentures and sought broader authorisation for debt issuance, underscoring active capital-market positioning around the stock.

6 min readRead →

Frontier AI & Machine Learning14 Oct 2026, 05:32 PM IST

Cambridge Heavy Industries Quietly Builds Desktop Fusion Device to Seed Next Wave of Power Plants

Cambridge Heavy Industries is developing a small, laser-powered fusion device that could serve as a proving ground for the technologies needed in future commercial fusion plants. The effort underscores a growing industry strategy: shrink the physics problem first, then scale the engineering later. While the company has kept the program largely out of public view, the move signals intensifying competition to turn fusion from a laboratory milestone into an industrial platform.

6 min readRead →

National Governance & Policy14 Oct 2026, 08:34 AM IST

Heavy Industries Ministry, CPSEs and Autonomous Bodies Review Special Campaign 6

The Ministry of Heavy Industries, along with its central public sector enterprises and autonomous bodies, has reviewed progress under Special Campaign 6, a government-wide cleanliness and efficiency drive. The exercise underscores New Delhi’s continuing push to improve administrative discipline, reduce pendency and strengthen public-facing governance across state-linked institutions.

5 min readRead →

Markets, IPOs & Wealth14 Oct 2026, 02:45 AM IST

PTC Industries, Aditya Infotech Among Four BSE 500 Stocks at Fresh 52-Week Highs as Sensex Surges

Four BSE 500 stocks, including PTC Industries and Aditya Infotech, touched fresh 52-week highs on Tuesday as the Sensex jumped 1,109 points, extending a broad market rally into select high-momentum counters. The gains, which have reached as much as 14% over the past month, suggest continued institutional and retail buying interest in names with strong relative strength.

5 min readRead →

Markets, IPOs & Wealth13 Oct 2026, 09:35 PM IST

PTC Industries, Aditya Infotech Among Four BSE 500 Stocks to Hit 52-Week Highs as Sensex Surges

Four BSE 500 stocks, including PTC Industries and Aditya Infotech, touched fresh 52-week highs on Tuesday as the Sensex jumped 1,109 points, extending a broad market rebound. The move underscores sustained buying interest in select counters, with the group advancing by as much as 14% over the past month despite a volatile macro backdrop.

5 min readRead →

Macro Economy & Fiscal Policy12 Oct 2026, 04:04 AM IST

Eight Midcap Stocks Surge Up to 135% in a Year as Laurus Labs, Apar Industries Become Multibaggers

A narrow set of midcap stocks has delivered outsized gains over the past year, with eight names rising between 50% and 135% and outperforming the broader market by a wide margin. Laurus Labs and Apar Industries stood out as multibaggers, more than doubling investor wealth during the period, underscoring the market’s preference for earnings visibility and sector-specific strength.

5 min readRead →

National Governance & Policy09 Oct 2026, 05:57 PM IST

KVIC Chairman Manoj Goyal Inaugurates Special Khadi and Village Industries Exhibition at Delhi Haat

Khadi and Village Industries Commission Chairman Manoj Goyal inaugurated a special Khadi and village industries exhibition at Delhi Haat, INA, under the broader Khadi Mahotsav-2026 initiative. The event is positioned as both a retail showcase and a policy signal, underscoring the government’s continuing emphasis on artisanal livelihoods, rural enterprise, and domestic manufacturing promotion.

6 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Sun Pharmaceutical Industries Ltd.:

New Delhi(1)India(1)